Randomized Trial of Adult Subjects With Generalized Anxiety Disorder

Conditions

Mental Health & Behavioral Research

Phase III

Volunteers
Health Professionals

What is the purpose of this trial?

The purpose of this study is to compare the efficacy of BHV-4157 versus placebo in subjects with Generalized Anxiety Disorder.

Ages
18 - 65 years
Gender
Both

Find out more about who can participate in this trial

Trial with
Biohaven Pharmaceutical Inc.
Start Date
04/30/2019
End Date
10/19/2019

For more information about this study, contact:

David Zakur

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

Volunteer Now

Principal Investigator

Michael Bloch, MD, MS
Associate Professor in the Child Study Center; Associate Director, Albert J. Solnit Integrated Training Program; Associate Director of the Tic and OCD Program

Sub-Investigator

Angie Landeros-Weisenberger, MD

Last Updated
08/01/2019
Study HIC
#2000024951

Randomized Trial of Adult Subjects With Generalized Anxiety Disorder

Conditions

Volunteers

Health Professionals

What is the purpose of this trial?

I'm interested in volunteering

Principal Investigator

Sub-Investigator

Contact Information